Re:Guillain-Barré Syndrome After Covid-19 Vaccination in US ...
by walterbell on Thursday December 09, 2021 @04:49PM
(#29503415)
For global data, search for "covid-19 vaccine" at http://vigiaccess.org/. Be sure to read the long disclaimer on the page.
> VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunization (AEFIs) – are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring (PIDM). WHO PIDM was created in 1968 to ensure the safer and more effective use of medicinal products.
The US VAERS database has about 50/50 US and foreign reports. It is simultaneously criticized as unverified (i.e. GIGO) and missing data due to disincentives against reporting. If you have a vaccine lot number, replace the last six characters in this sample query URL, for a summary of adverse events. The raw data can be download and imported into a SQL database for deeper analysis: https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=...
US Vaccine Safety Datalink (the source for the paper in this article) has data from some HMOs. The raw data is not available to the public. https://pubmed.ncbi.nlm.nih.gov/21502240/
> The Vaccine Safety Datalink (VSD) project is a collaborative project between the Centers for Disease Control and Prevention and 8 managed care organizations (MCOs) in the United States. Established in 1990 to conduct postmarketing evaluations of vaccine safety, the project has created an infrastructure that allows for high-quality research and surveillance. The 8 participating MCOs comprise a large population of 8.8 million members annually (3% of the US population), which enables researchers to conduct studies that assess adverse events after immunization.
> VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunization (AEFIs) – are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring (PIDM). WHO PIDM was created in 1968 to ensure the safer and more effective use of medicinal products.
The US VAERS database has about 50/50 US and foreign reports. It is simultaneously criticized as unverified (i.e. GIGO) and missing data due to disincentives against reporting. If you have a vaccine lot number, replace the last six characters in this sample query URL, for a summary of adverse events. The raw data can be download and imported into a SQL database for deeper analysis: https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=...
US Vaccine Safety Datalink (the source for the paper in this article) has data from some HMOs. The raw data is not available to the public. https://pubmed.ncbi.nlm.nih.gov/21502240/
> The Vaccine Safety Datalink (VSD) project is a collaborative project between the Centers for Disease Control and Prevention and 8 managed care organizations (MCOs) in the United States. Established in 1990 to conduct postmarketing evaluations of vaccine safety, the project has created an infrastructure that allows for high-quality research and surveillance. The 8 participating MCOs comprise a large population of 8.8 million members annually (3% of the US population), which enables researchers to conduct studies that assess adverse events after immunization.